Fluence

Dr. Ingmar Gorman is a psychologist who specializes in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr. Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is now the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. Along with Dr. Paleos, he is currently site co-principal investigator and therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.

Andrew is a psychedelic educator, harm reduction and integration coach, and certified mindfulness teacher. He has been working in some capacity with Fluence since before its inception, serving as an assisting trainer for early workshops and as a mentor for certificate program students. He also has over 15 years of experience working with various organizations on digital strategy, content, marketing, and technology, and has played a key role at Fluence in those areas through its early growth. Andrew has been practicing meditation since 2002, having studied mainly in the Tibetan Buddhist tradition before becoming interested in the clinical applications of mindfulness. He completed his training in Mindfulness-Based Stress Reduction with the Centre for Mindfulness Studies in 2018 and has been educating clinicians, therapists and the general public about psychedelics and their therapeutic applications since 2017. Prior to his work with Fluence he established the Psychedelic Harm Reduction and Integration program at Mindspace, and was the Director of Programming and Content at Numinus. He completed MAPS’s MDMA Therapy for PTSD training program in 2021 and is also the co-director of Plant Parenthood, a community organization that looks at the intersection of family, parenting, and the intentional therapeutic use of psychedelics. He came on board officially in October 2022 as Fluence’s VP of Marketing and Strategy.